According to a recent Future Market Insights (FMI) industry analysis, the demand in the high-end cellomics market is expected to top US$ 288.8 Mn in 2021, growing at a CAGR of 6.4% during the forecast period 2021-2031.
High-end cellomics is a process that is utilized in drug discovery and biological research to identify substances such as small molecules, RNAi or peptides which alter the phenotype of a cell in a wanted manner.
The global high-end cellomics market is primarily driven by increasing technological advancement in imaging solutions. Technological advancements such as the usage of polarization methods, multicolored fluorescence-based reagents, automated imaging technology, and flow cytometry are also anticipated to boost the market growth further.
Increasing investment in research and development in cellular science of novel molecules by private and government organizations, technological advancement in imaging solutions, and advantages related to these innovations such as improved scope for pplication in gene documentation & neonatal development learning will drive the high-end cellomics market.
Key Takeaways from High-end Cellomics Market Study
- The global high-end cellomics market is expected to reach US$ 536.9 Mn by 2031.
- By application, drug discovery accounted for 55.5% of overall sales in 2021 and is expected to continue to grow at the same trend during the forecast period.
- By end-users, pharmaceutical and biotechnology companies will account for the largest share of 51.8% during the forecast period.
- By region, North America held the largest share of 32.7% of the global high-end cellomics market.
- By country, the U.S. is the most lucrative market in the global high-end cellomics market with US$ 81.7 Mn revenue in 2021.
Request Sample PDF Brochure:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14164
Who is Winning?
Some of the leading manufacturers of high-end cellomics are focusing on product approvals and launch strategies for global expansion objectives, thereby, enhancing their market presence. The leading key players are focusing on strategic alliance to expand the product offerings.
Yokogawa Electronic Corporation in December 2020, agreed with InSphero AG to jointly promote the use of Yokogawa’s high-end cellomics systems for drug discovery research which actively involves the use of 3D in vitro models.
The key market players covered by FMI include PerkinElmer, Inc., ThermoFisher Scientific, Inc., Molecular Devices LLC (part of Danaher Corporation) and Yokogawa Electric Corporation.
About the Healthcare Division at Future Market Insights
Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here
High-end Cellomics Market by Category
Application:
- Academic Research/Basic Research
- Drug Discovery
- Primary & Secondary Screening
- Target Identification & Validation
- Invitro Toxicity Studies
- Compound Profiling
End-User:
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Independent Contract Research Organizations (CROs)
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa (MEA)
Ask for Customization:
https://www.futuremarketinsights.com/customization-available/rep-gb-14164
Table of Content
- Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
- Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion & Exclusion
- Key Trends
3.1. Key Trends Impacting the Market
3.2. Trends in Diverse Application
- Key Success Factors
4.1. Key Products USP Analysis
4.2. Key Manufacturers Promotional Strategies
4.3. Value Chain Analysis
4.4. PESTLE Analysis
4.5. PORTERS Analysis
4.6. Key Regulations
Inquire Before Buying Research Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-14164
Have a Look at Related Research Reports of Healthcare
Bone Cement Delivery Systems Market Value is predicted to witness US$ 830 Mn in 2022 and is expected to exhibit a CAGR of 6.9% from 2022 to reach US$ 1730 Mn by 2032
Articulating Paper Forceps Market Sales is estimated to reach US$ 1.4 Bn in 2022, and is anticipated to reach US$ 2.3 Bn by 2032
Perfusion Imaging Market Forecast is likely to exhibit the said growth at a CAGR of 6.8% during the forecast period from 2022 to 2032
About Us
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/high-end-cellomics-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
The post High-end Cellomics Market Trends, Demand, Share Analysis to 2031 appeared first on Future Market Insights.
